Extended Chemotherapy for Residual Disease after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in High Risk Neuroblastoma

被引：0
|
作者：
Park, H. J. [1 ]
Choi, J. Y. [1 ]
Kang, H. J. [1 ]
Kim, B. K. [1 ]
Hong, K. T. [1 ]
Kim, H. -Y. [2 ]
Park, S. -H. [3 ]
Cheon, J. -E. [4 ]
Kim, I. H. [5 ]
Cheon, G. J. [6 ]
Shin, H. Y. [1 ]
机构：
[1] Seoul Natl Univ, Pediat, Coll Med, Seoul, South Korea
[2] Seoul Natl Univ, Pediat Surg, Coll Med, Seoul, South Korea
[3] Seoul Natl Univ, Pathol, Coll Med, Seoul, South Korea
[4] Seoul Natl Univ, Radiol, Coll Med, Seoul, South Korea
[5] Seoul Natl Univ, Radiat Oncol, Coll Med, Seoul, South Korea
[6] Seoul Natl Univ, Nucl Med, Coll Med, Seoul, South Korea
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0588
引用
收藏
页码：S266 / S266
页数：1
相关论文
共 50 条
  • [1] Predictors of survival in patients with high-risk neuroblastoma who failed tandem high-dose chemotherapy and autologous stem cell transplantation
    Yi, Eun Sang
    Son, Meong Hi
    Hyun, Ju Kyung
    Cho, Hee Won
    Ju, Hee Young
    Lee, Ji Won
    Yoo, Keon Hee
    Sung, Ki Woong
    Koo, Hong Hoe
    PEDIATRIC BLOOD & CANCER, 2020, 67 (02)
  • [2] Predictors of Survival in Patients with High-Risk Neuroblastoma who Failed Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation
    Yi, E. S.
    Son, M. H.
    Ma, Y. E.
    Cho, H. W.
    Ju, H. Y.
    Lee, J. W.
    Yoo, K. H.
    Sung, K. W.
    Koo, H. H.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S345 - S345
  • [3] Tandem high-dose chemotherapy with thiotepa and busulfan–melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients
    C Pasqualini
    C Dufour
    G Goma
    M-A Raquin
    V Lapierre
    D Valteau-Couanet
    Bone Marrow Transplantation, 2016, 51 : 227 - 231
  • [4] TANDEM HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL RESCUE IN HIGH RISK NEUROBLASTOMA PATIENTS: A SINGLE CENTER EXPERIENCE
    Kim, S. J.
    Kim, H.
    Lee, J. W.
    Park, K. D.
    Shin, H. Y.
    Ahn, H. S.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S374 - S374
  • [5] TANDEM HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL RESCUE IN HIGH RISK NEUROBLASTOMA PATIENTS: A SINGLE CENTER EXPERIENCE
    Ahn, H. S.
    Kim, S.
    Lee, J. W.
    Kang, H. J.
    Park, K. D.
    Yoo, E. S.
    Ryu, K. H.
    Kim, H. Y.
    Park, K. W.
    Lee, K. S.
    Choi, Y. M.
    Shin, H. Y.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 111 - 111
  • [6] High-dose chemotherapy and autologous blood stem cell transplantation in children with metastatic neuroblastoma
    Kai, T
    Ishii, E
    Matsuzaki, A
    Inaba, S
    Suita, S
    Ueda, K
    ACTA PAEDIATRICA JAPONICA, 1997, 39 (01): : 54 - 60
  • [7] Tandem high-dose chemotherapy with thiotepa and busulfan-melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients
    Pasqualini, C.
    Dufour, C.
    Goma, G.
    Raquin, M-A
    Lapierre, V.
    Valteau-Couanet, D.
    BONE MARROW TRANSPLANTATION, 2016, 51 (02) : 227 - 231
  • [8] Iron Overload during Follow-up after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma
    Bae, Soo Jin
    Kang, Christine
    Sung, Ki Woong
    Chueh, Hee Won
    Son, Meong Hi
    Lee, Soo Hyun
    Yoo, Keon Hee
    Koo, Hong Hoe
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (04) : 363 - 369
  • [9] Clinical implication of residual MIBG-positive disease in the follow-up of high-risk neuroblastoma treated with tandem high-dose chemotherapy and autologous stem cell transplantation
    Seo, Eun Seop
    Shin, Muheon
    Lim, Hana
    Cho, Hee Won
    Ju, Hee Young
    Cho, Young-Seok
    Yoo, Keon Hee
    Koo, Hong Hoe
    Lee, Ji Won
    Sung, Ki Woong
    PEDIATRIC BLOOD & CANCER, 2022, 69 (07)
  • [10] TANDEM HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR INITIAL PULMONARY METASTASES
    Park, Hyun Jin
    Hong, Kyung Taek
    Choi, Jung Yoon
    Kim, Bo Kyung
    Kim, Han-Soo
    Park, Sung-Hye
    Cheon, Jung-Eun
    Kang, Hyoung Jin
    PEDIATRIC BLOOD & CANCER, 2023, 70
12345